• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

源自生姜的6-姜烯酚抑制肠道隐窝干细胞分化并增加肠易激综合征风险。

6-Shogaol Derived from Ginger Inhibits Intestinal Crypt Stem Cell Differentiation and Contributes to Irritable Bowel Syndrome Risk.

作者信息

Zhao Bing, Ye Juan, Zhao Wenjing, Liu Xinyu, Lan Hongli, Sun Jinbing, Chen Jiao, Cai Xueting, Wei Qingyun, Zhou Qian, Zhang Zhengwei, Wu Yuze, Yang Yang, Cao Peng

机构信息

State Key Laboratory on Technologies for Chinese Medicine Pharmaceutical Process Control and Intelligent Manufacture, Nanjing University of Chinese Medicine, Nanjing, China.

Jiangsu Provincial Medical Innovation Center, Affiliated Hospital of Integrated Traditional Chinese and Western Medicine, Nanjing University of Chinese Medicine, Nanjing, China.

出版信息

Research (Wash D C). 2024 Nov 7;7:0524. doi: 10.34133/research.0524. eCollection 2024.

DOI:10.34133/research.0524
PMID:39512446
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11542252/
Abstract

Dietary factors play a crucial role in irritable bowel syndrome (IBS) pathogenesis. Therefore, the dietary contraindications for patients with IBS require further supplementation. Recent investigations have revealed that ginger consumption may pose a risk of aggravating the symptoms and incidence of IBS; however, the specific mechanism remains unknown. In this study, we developed experimental IBS and intestinal organoid differentiation screening models to elucidate the mechanisms underlying the ginger-mediated exacerbation of IBS symptoms. Subsequently, we used a knockout approach combined with click chemistry as well as virus infection to identify the toxic components of ginger and the target mechanism. Our results showed that a daily intake of 90 to 300 mg/kg ginger (equivalent to a human daily dose of 0.6 to 2 g per person) may pose a risk of exacerbating IBS symptoms. Furthermore, a component derived from 6-gingerol (ginger's main ingredient) through in vivo gastric acid and heat processing inhibited the formation of the eIF3 transcription initiation complex by covalently binding to the Cys site of eIF3A, a key factor regulating intestinal crypt stem cell differentiation, further reducing the goblet cell number and related mucus layer thickness and increasing lipopolysaccharide infiltration and low-grade inflammation in the ileum crypts, thereby exacerbating the symptoms of IBS in mice. Our study suggests that dietary ginger aggravates IBS and provides safety evaluation methods for the proper use of foods in specific populations.

摘要

饮食因素在肠易激综合征(IBS)的发病机制中起着关键作用。因此,IBS患者的饮食禁忌需要进一步补充。最近的研究表明,食用生姜可能会加重IBS的症状和发病率;然而,具体机制尚不清楚。在本研究中,我们建立了实验性IBS和肠道类器官分化筛选模型,以阐明生姜介导的IBS症状加重的潜在机制。随后,我们采用基因敲除方法结合点击化学以及病毒感染来鉴定生姜的毒性成分和靶标机制。我们的结果表明,每天摄入90至300mg/kg生姜(相当于人类每人每天0.6至2g的剂量)可能会有加重IBS症状的风险。此外,一种由6-姜酚(生姜的主要成分)经体内胃酸和热处理衍生而来的成分,通过与eIF3A的半胱氨酸位点共价结合,抑制eIF3转录起始复合物的形成,eIF3A是调节肠道隐窝干细胞分化的关键因子,进而减少杯状细胞数量和相关黏液层厚度,并增加回肠隐窝中脂多糖的浸润和低度炎症,从而加重小鼠IBS的症状。我们的研究表明,食用生姜会加重IBS,并为特定人群合理使用食物提供了安全性评估方法。

相似文献

1
6-Shogaol Derived from Ginger Inhibits Intestinal Crypt Stem Cell Differentiation and Contributes to Irritable Bowel Syndrome Risk.源自生姜的6-姜烯酚抑制肠道隐窝干细胞分化并增加肠易激综合征风险。
Research (Wash D C). 2024 Nov 7;7:0524. doi: 10.34133/research.0524. eCollection 2024.
2
Ginger relieves intestinal hypersensitivity of diarrhea predominant irritable bowel syndrome by inhibiting proinflammatory reaction.姜黄通过抑制促炎反应缓解腹泻型肠易激综合征的肠道高敏感性。
BMC Complement Med Ther. 2020 Sep 14;20(1):279. doi: 10.1186/s12906-020-03059-3.
3
Chitin-glucan improves important pathophysiological features of irritable bowel syndrome.几丁质-葡聚糖可改善肠易激综合征的重要病理生理特征。
World J Gastroenterol. 2024 Apr 28;30(16):2258-2271. doi: 10.3748/wjg.v30.i16.2258.
4
Is ginger effective for the treatment of irritable bowel syndrome? A double blind randomized controlled pilot trial.姜治疗肠易激综合征有效吗?一项双盲随机对照试验。
Complement Ther Med. 2014 Feb;22(1):17-20. doi: 10.1016/j.ctim.2013.12.015. Epub 2014 Jan 8.
5
Consumption of spicy foods and the prevalence of irritable bowel syndrome.辛辣食物的消费与肠易激综合征的流行。
World J Gastroenterol. 2013 Oct 14;19(38):6465-71. doi: 10.3748/wjg.v19.i38.6465.
6
MicroRNA-16 inhibits the TLR4/NF-κB pathway and maintains tight junction integrity in irritable bowel syndrome with diarrhea.微小 RNA-16 抑制 TLR4/NF-κB 通路并维持腹泻型肠易激综合征中的紧密连接完整性。
J Biol Chem. 2022 Nov;298(11):102461. doi: 10.1016/j.jbc.2022.102461. Epub 2022 Sep 5.
7
Sinisan Alleviates Stress-Induced Intestinal Dysfunction and Depressive-like Behaviors in Mice with Irritable Bowel Syndrome by Enhancing the Intestinal Barrier and Modulating Central 5-Hydroxytryptamine.辛夷安神方通过增强肠道屏障和调节中枢 5-羟色胺缓解肠易激综合征小鼠的应激诱导的肠道功能障碍和抑郁样行为。
Int J Mol Sci. 2024 Sep 24;25(19):10262. doi: 10.3390/ijms251910262.
8
Baizhu shaoyao decoction restores the intestinal barrier and brain-gut axis balance to alleviate diarrhea-predominant irritable bowel syndrome via FoxO1/FoxO3a.白术芍药汤通过FoxO1/FoxO3a恢复肠屏障和脑-肠轴平衡以缓解腹泻型肠易激综合征。
Phytomedicine. 2024 Jan;122:155163. doi: 10.1016/j.phymed.2023.155163. Epub 2023 Oct 26.
9
Promotion of Mitochondrial Biogenesis via Activation of AMPK-PGC1ɑ Signaling Pathway by Ginger (Zingiber officinale Roscoe) Extract, and Its Major Active Component 6-Gingerol.姜(Zingiber officinale Roscoe)提取物及其主要活性成分 6-姜酚通过激活 AMPK-PGC1α 信号通路促进线粒体生物发生。
J Food Sci. 2019 Aug;84(8):2101-2111. doi: 10.1111/1750-3841.14723. Epub 2019 Aug 1.
10
Using ultra-performance liquid chromatography with linear ion trap-electrostatic field orbitrap mass spectrometry, network pharmacology, and molecular docking to explore the constituent targets and action mechanisms of decoction of Angelica sinensis, Zingiberis Rhizoma Recens, and Mutton in the treatment of diarrhea-predominant irritable bowel syndrome.采用超高效液相色谱-线性离子阱-静电场轨道阱质谱联用、网络药理学和分子对接技术,探讨当归生姜羊肉汤治疗腹泻型肠易激综合征的组成靶点和作用机制。
J Pharm Pharmacol. 2024 May 3;76(5):462-478. doi: 10.1093/jpp/rgad076.

引用本文的文献

1
Reunderstanding the classical prescription Banxia Xiexin Decoction: new perspectives from a comprehensive review of clinical research and pharmacological studies.重新认识经典方剂半夏泻心汤:基于临床研究与药理研究全面综述的新视角
Chin Med. 2025 Mar 18;20(1):39. doi: 10.1186/s13020-025-01087-0.
2
An abundant ginger compound furanodienone alleviates gut inflammation via the xenobiotic nuclear receptor PXR in mice.一种丰富的生姜化合物呋喃二烯酮通过小鼠体内的外源性核受体PXR减轻肠道炎症。
Nat Commun. 2025 Feb 3;16(1):1280. doi: 10.1038/s41467-025-56624-0.

本文引用的文献

1
The effects of capsaicin intake on weight loss among overweight and obese subjects: a systematic review and meta-analysis of randomised controlled trials.辣椒素摄入对超重和肥胖受试者体重减轻的影响:随机对照试验的系统评价和荟萃分析。
Br J Nutr. 2023 Nov 14;130(9):1645-1656. doi: 10.1017/S0007114523000697. Epub 2023 Mar 20.
2
Evaluation of two laboratory model methods for diarrheal irritable bowel syndrome.两种腹泻型肠易激综合征实验室模型方法的评估。
Mol Med. 2023 Jan 12;29(1):5. doi: 10.1186/s10020-022-00599-x.
3
Paeoniflorin alleviates inflammatory response in IBS-D mouse model via downregulation of the NLRP3 inflammasome pathway with involvement of miR-29a.
芍药苷通过下调NLRP3炎性小体途径并涉及miR-29a减轻IBS-D小鼠模型中的炎症反应。
Heliyon. 2022 Dec 15;8(12):e12312. doi: 10.1016/j.heliyon.2022.e12312. eCollection 2022 Dec.
4
Irritable bowel syndrome: treatment based on pathophysiology and biomarkers.肠易激综合征:基于病理生理学和生物标志物的治疗。
Gut. 2023 Mar;72(3):590-599. doi: 10.1136/gutjnl-2022-328515. Epub 2022 Oct 28.
5
Material Engineering in Gut Microbiome and Human Health.肠道微生物群与人类健康中的材料工程
Research (Wash D C). 2022 Jul 20;2022:9804014. doi: 10.34133/2022/9804014. eCollection 2022.
6
The Role of Dihydroresveratrol in Enhancing the Synergistic Effect of Li01 and Resveratrol in Ameliorating Colitis in Mice.二氢白藜芦醇在增强Li01与白藜芦醇协同改善小鼠结肠炎作用中的角色
Research (Wash D C). 2022 Jun 14;2022:9863845. doi: 10.34133/2022/9863845. eCollection 2022.
7
Organoid-derived intestinal epithelial cells are a suitable model for preclinical toxicology and pharmacokinetic studies.类器官衍生的肠上皮细胞是临床前毒理学和药代动力学研究的合适模型。
iScience. 2022 Jun 7;25(7):104542. doi: 10.1016/j.isci.2022.104542. eCollection 2022 Jul 15.
8
Assay establishment and validation of a high-throughput organoid-based drug screening platform.建立和验证高通量类器官药物筛选平台的方法。
Stem Cell Res Ther. 2022 May 26;13(1):219. doi: 10.1186/s13287-022-02902-3.
9
Irritable Bowel Syndrome: Food as a Friend or Foe?肠易激综合征:食物是朋友还是敌人?
Gastroenterol Clin North Am. 2021 Mar;50(1):183-199. doi: 10.1016/j.gtc.2020.10.002. Epub 2020 Dec 27.
10
Irritable bowel syndrome.肠易激综合征。
Lancet. 2020 Nov 21;396(10263):1675-1688. doi: 10.1016/S0140-6736(20)31548-8. Epub 2020 Oct 10.